Brief: Catalyst Pharmaceuticals Announces FDA Acceptance Of The Supplemental New Drug Application For FIRDAPSE®

Catalyst Pharmaceuticals

13/10/2023 13:30

Oct 13 (Reuters) - Catalyst Pharmaceuticals Inc
 CPRX.O :
    * CATALYST PHARMACEUTICALS ANNOUNCES FDA ACCEPTANCE OF THE
SUPPLEMENTAL NEW DRUG APPLICATION FOR FIRDAPSE®
    * CATALYST PHARMACEUTICALS INC - U.S. FDA ASSIGNED TARGET
ACTION
DATE OF JUNE 4, 2024

Source text for Eikon:  ID:nGNX8LScmz 
Further company coverage:  CPRX.O 

 ((Reuters.Briefs@thomsonreuters.com))